paracetamol hikma 10 mg/ml infusionslösung
hikma pharma gmbh (3220831) - paracetamol - infusionslösung - teil 1 - infusionslösung; paracetamol (01212) 10 milligramm
idarubicin hikma 1 mg/ml injektionslösung
hikma pharma gmbh (3220831) - idarubicinhydrochlorid - injektionslösung - 1 mg/ml - teil 1 - injektionslösung; idarubicinhydrochlorid (25766) 1 milligramm
bortezomib hikma 3,5 mg pulver zur herstellung einer injektionslösung
hikma pharma gmbh (3220831) - bortezomibanhydrid - pulver zur herstellung einer injektionslösung - teil 1 - pulver zur herstellung einer injektionslösung; bortezomibanhydrid (43230) 3,336 milligramm
bortezomib hikma 3,5 mg pulver zur herstellung einer injektionslösung
hikma pharma gmbh - bortezomib -
amlodipine besylate tablet
hikma pharmaceuticals usa inc. - amlodipine besylate (unii: 864v2q084h) (amlodipine - unii:1j444qc288) - amlodipine 2.5 mg - amlodipine besylate tablets are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including amlodipine besylate tablets. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a variety of pharmacologic
hikma heparin 5000 iu/ml solution for injection
hikma pharmaceuticals plc, jordan - heparin sodium - solution for injection - 5000 iu/ml
cefuroxim hikma 1500 mg pulver zur herstellung einer injektions- bzw. infusionslösung
hikma farmaceutica (portugal) s.a. - cefuroxim-natrium - cefuroxim
cefuroxim hikma 750 mg pulver zur herstellung einer injektionslösung
hikma farmaceutica (portugal) s.a. - cefuroxim-natrium - cefuroxim
cisatracúrio hikma 2 mg/ml solução injetável ou para perfusão
hikma farmacêutica (portugal), s.a. - besilato de cisatracúrio - solução injetável ou para perfusão - 2 mg/ml - besilato de cisatracúrio 2.68 mg/ml - cisatracurium - genérico - duração do tratamento: curta ou média duração